Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 17/20 | 0.62 |
| ▸ | CTSD | P07339 | 2/20 | 0.59 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.58 |
| ▸ | FNTA | P49354 | 1/20 | 0.53 |
| ▸ | FNTB | P49356 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29350817 | 0.92 | BACE1 (0.66) | BACE1CTSDBACE2FNTAFNTB | |
| SCHEMBL30607497 | 0.92 | BACE1 (0.66) | BACE1CTSDBACE2 | |
| SCHEMBL30001080 | 0.91 | BACE1 (0.55) | BACE1CTSDBACE2FNTAFNTB | |
| SCHEMBL2980533 | 0.91 | MME (0.57) | BACE1 | |
| SCHEMBL5970186 | 0.91 | MME (0.57) | BACE1 | |
| SCHEMBL30117298 | 0.90 | BACE1 (0.64) | BACE1CTSDBACE2 | |
| SCHEMBL30567794 | 0.90 | BACE1 (0.67) | BACE1CTSDBACE2 | |
| SCHEMBL29532230 | 0.88 | BACE1 (0.61) | BACE1CTSDBACE2FNTAFNTB | |
| SCHEMBL29350741 | 0.88 | FNTA (0.56) | BACE1CTSDBACE2FNTAFNTB | |
| SCHEMBL8821945 | 0.88 | MME (0.55) | BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250339504-A1 | CANCER VACCINE WITH USE OF COMMON CANCER ANTIGEN COCKTAIL, TCR/CAR-T CELL THERAPEUTIC, COMPANION DIAGNOSTIC METHOD, AND METHOD FOR DIAGNOSING RISK OF CANCER ONSET BY DETECTING CIRCULATING TUMOR CELLS | NATIONAL CANCER CENTER (JP) | 2025-11-06 | — | — | US | disclosed |
| WO-2024163874-A2 | STABLE AND CONTROLLED RELEASE FORMULATIONS OF NEUREGULIN-4 ANALOGS | AVEXEGEN THERAPEUTICS, INC. (US) | 2024-08-08 | — | — | WO | disclosed |